phase 3 imvigor130 results: atezolizumab in untreated metastatic urothelial carcinoma
Published 4 years ago • 94 plays • Length 2:57Download video MP4
Download video MP3
Similar videos
-
2:18
final os results of imvigor130: 1l atezolizumab /- chemotherapy in metastatic urothelial carcinoma
-
0:48
imvigor130: 1l atezolizumab /- chemotherapy in metastatic urothelial carcinoma
-
2:30
final os results of imvigor130: atezolizumab plus platinum/gemcitabine for muc
-
4:20
imvigor130 data: atezolizumab alone or with chemo upfront for bladder cancer
-
5:27
imvigor130: atezolizumab with or without chemotherapy in metastatic urothelial cancer
-
7:21
imvigor130: atezolizumab /- platinum-based chemo upfront for advanced urothelial carcinoma
-
1:55
imvigor130: a post-hoc analysis of atezolizumab monotherapy in urothelial carcinoma
-
1:10
matthew galsky, md, tells us about the phase 3 imvigor130 study in advanced urothelial cancer
-
1:37
dr. zhang on the imvigor130 trial in metastatic urothelial cancer
-
3:12
imvigor130: os data for atezolizumab plus chemo versus chemo alone
-
2:06
imvigor130: clinical implications and next steps
-
0:52
dr. davis on imvigor130 trial in metastatic urothelial cancer
-
2:15
key findings on atezolizumab for muc from imvigor130
-
1:25
dr. balar on imvigor 210 results for metastatic urothelial carcinoma
-
4:55
atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma
-
3:03
imvigor130: immunotherapy added to chemotherapy in metastatic urothelial cancer
-
3:00
atezolizumab limits disease progression for metastatic urothelial bladder cancer
-
0:16
imvigor 210 results in metastatic urothelial carcinoma
-
3:34
abacus trial: preoperative atezolizumab in urothelial carcinoma